Your browser doesn't support javascript.
loading
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
Arai, Hiroyuki; Elliott, Andrew; Millstein, Joshua; Xiu, Joanne; Ou, Fang-Shu; Innocenti, Federico; Wang, Jingyuan; Battaglin, Francesca; Jayachandran, Priya; Kawanishi, Natsuko; Soni, Shivani; Zhang, Wu; Sohal, Davendra; Goldberg, Richard M; Hall, Michael J; Scott, Aaron J; Khushman, Mohd; Hwang, Jimmy J; Lou, Emil; Weinberg, Benjamin A; Lockhart, Albert Craig; Shields, Anthony Frank; Abraham, Jim P; Magee, Daniel; Stafford, Phillip; Zhang, Jian; Venook, Alan P; Korn, W Michael; Lenz, Heinz-Josef.
Affiliation
  • Arai H; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Elliott A; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Millstein J; Department of Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Xiu J; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Ou FS; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Innocenti F; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Wang J; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Battaglin F; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Jayachandran P; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Kawanishi N; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Soni S; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Zhang W; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Sohal D; Division of Hematology/Oncology, University of Cincinnati, Cincinnati, OH, USA.
  • Goldberg RM; West Virginia University Cancer Institute, Morgantown, WV, USA.
  • Hall MJ; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Scott AJ; Division of Hematology and Oncology, Department of Medicine, Banner-University of Arizona, Tucson, AZ, USA.
  • Khushman M; Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, AL, USA.
  • Hwang JJ; Department of Solid Tumor Oncology, GI Medical Oncology, Levine Cancer Institute, Charlotte, NC, USA.
  • Lou E; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
  • Weinberg BA; Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Lockhart AC; Department of Medicine, Division of Oncology, University of Miami, Miller School of Medicine, Miami, FL, USA.
  • Shields AF; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
  • Abraham JP; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Magee D; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Stafford P; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Zhang J; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Venook AP; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Korn WM; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. lenz@usc.edu.
Oncogene ; 41(2): 260-267, 2022 01.
Article in En | MEDLINE | ID: mdl-34728807
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Neurofibromin 1 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Neurofibromin 1 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Estados Unidos